GLENMARK.BO

GLENMARK PHARMACEUTICALS LTD. · Healthcare · Pharmaceuticals

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$168.55B

PE Ratio

4.481532295516493

EV to Ebitda

—

Earnings Yield

1846020482.30%

Revenue (TTM)

$1.31B

Net Income (TTM)

$331.7M

Revenue (Annual YoY Growth)

—

Revenue (Quarterly YoY Growth)

4.90%

Profit Margin

8.33%

Return on Equity

—

Debt to Equity Ratio

0.4130395542169883

Dividend Yield

0.00%

All fundamentals

Core6 fields›

Market Cap$168.55B

Revenue TTM$1.31B

Shares Outstanding282.2M

Float138380198

Insider Ownership50.52%

Institutional Ownership19.43%

Growth Estimates5 fields›

Revenue Growth (Quarterly YoY)4.90%

Rev Growth Est 1Y Forward0.1160

EPS Growth (Quarterly YoY)-8.50%

EPS Growth Est Quarterly7.82

LT EPS Growth Estimates20.90%

Operations15 fields›

Revenue TTM$1.31B

Gross Margin TTM62.89%

Gross Margin (Quarterly)65.43%

Operating Margin TTM13.78%

Operating Margin (Quarterly)13.80%

Profit Margin TTM8.33%

Profit Margin (Quarterly)26.32%

Net Income TTM$331.7M

EPS TTM31.87

EBIT Margin TTM15.86%

EBITDA TTM$207.0M

CFO % of Revenue (Quarterly)5.98%

Capex % of Revenue TTM10.37%

Capital Expenditures$135.4M

FCF % of Revenue (Quarterly)2.95%

Efficiency1 fields›

ROA6.43%

Valuation7 fields›

P/E (TTM)4.481532295516493

P/E Forward14.9031

EV/Revenues (TTM)1.2553

Price To Book1.2845260533696128

Earnings Yield1846020482.30%

Dividend Yield0.00%

Payout Ratio23.18%

Liquidity8 fields›

Cash Per Share49.9888435321689

Current Ratio1.7661733374475497

Goodwill & Intangibles$24185.69T

Total Assets$180308.53T

Total Liabilities$3.85B

Shareholders Equity$95730.88T

Debt to Equity0.4130395542169883

Interest Expense$2.97B

Yields3 fields›

Dividend Yield0.00%

Payout Ratio23.18%

Earnings Yield1846020482.30%